BioCentury | Jan 6, 2021
Deals

Jan. 5 Quick Takes: Myriad restructuring; plus ViGeneron-Biogen, Rhythm, Sosei and more

...alternatives for its contract research services and dermatology businesses.ViGeneron, Biogen eye diseases gene therapy deal ViGeneron Gmbh...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...investors WuXi AppTec, Huimei Capital and Alwin Capital. Gene therapy play ViGeneron raises series A ViGeneron GmbH...
...receptor alpha 1; VEGF - Vascular endothelial growth factor BC Staff Transcenta Holding Ltd. Kodiak Sciences Inc. Aslan Pharmaceuticals Ltd. ViGeneron GmbH ...
Items per page:
1 - 2 of 2
BioCentury | Jan 6, 2021
Deals

Jan. 5 Quick Takes: Myriad restructuring; plus ViGeneron-Biogen, Rhythm, Sosei and more

...alternatives for its contract research services and dermatology businesses.ViGeneron, Biogen eye diseases gene therapy deal ViGeneron Gmbh...
BioCentury | Dec 3, 2019
Financial News

Dec. 2 Financial Quick Takes: Kodiak gains on royalty deal; plus Clover, Aslan, Transcenta, EOC, Hui-Gene and ViGeneron

...investors WuXi AppTec, Huimei Capital and Alwin Capital. Gene therapy play ViGeneron raises series A ViGeneron GmbH...
...receptor alpha 1; VEGF - Vascular endothelial growth factor BC Staff Transcenta Holding Ltd. Kodiak Sciences Inc. Aslan Pharmaceuticals Ltd. ViGeneron GmbH ...
Items per page:
1 - 2 of 2